BlackRock Fund Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9.22M	Buy	1,195,897 +123,726	+12%	+$1.14M	﹤0.01%	2617
2016 Q3	$12.3M	Buy	1,072,171 +232,783	+28%	+$2.71M	﹤0.01%	2342
2016 Q2	$10.3M	Buy	839,388 +15,990	+2%	+$194K	﹤0.01%	2394
2016 Q1	$8.32M	Buy	823,398 +19,418	+2%	+$228K	﹤0.01%	2461
2015 Q4	$18.1M	Sell	803,980 -71,048	-8%	-$1.46M	﹤0.01%	2112
2015 Q3	$14.5M	Buy	875,028 +47,619	+6%	+$955K	﹤0.01%	2189
2015 Q2	$18.6M	Buy	827,409 +100,028	+14%	+$2.47M	﹤0.01%	2152
2015 Q1	$18.8M	Buy	727,381 +19,790	+3%	+$502K	﹤0.01%	2111
2014 Q4	$15.4M	Buy	707,591 +41,745	+6%	+$855K	﹤0.01%	2209
2014 Q3	$12.6M	Buy	665,846 +4,889	+0.7%	+$98.3K	﹤0.01%	2220
2014 Q2	$15.4M	Buy	660,957 +169,818	+35%	+$4.19M	﹤0.01%	2165
2014 Q1	$16.5M	Buy	491,139 +41,923	+9%	+$1.41M	﹤0.01%	2102
2013 Q4	$13.3M	Buy	449,216 +318,048	+242%	+$5.83M	﹤0.01%	2214
2013 Q3	$2.01M	Buy	+131,168	New	+$2.43M	﹤0.01%	3123